Muscular dystrophy is a term used to describe many different
muscular diseases caused by genetic defects.
Not exact matches
• Exonics Therapeutics, Inc, a Boston - based biotechnology company focused on developing SingleCut CRISPR technology to repair mutations
causing Duchenne
muscular dystrophy and other neuromuscular
diseases, raised $ 40 million in Series A funding.
According to studies, approximately one out of every 40 individuals in the United States is a carrier of the gene responsible for spinal
muscular atrophy (SMA), a neurodegenerative
disease that
causes muscles to weaken over time.
Spinal
muscular atrophy (SMA) is a devastating hereditary
disease that is a leading
cause of infant and early childhood mortality.
According to recent studies, approximately one out of every 40 individuals in the United States is a carrier of the gene responsible for spinal
muscular atrophy (SMA), a neurodegenerative
disease that
causes muscles to weaken over time.
Knowing the sex of a fetus is important when the mother is a carrier of an X-chromosome gene that can
cause a
disease such as
muscular dystrophy.
They had been working with a worm model of Duchenne
muscular dystrophy, a severe form of the
disease that strikes young boys and is
caused by mutations in the gene that encodes the dystrophin protein.
Muscular dystrophy, a
disease caused by a genetic mutation on the X chromosome, primarily affects boys and comes in several varieties.
In the last four years scientists have cloned and sequenced many genes carrying defects that
cause disease, including those responsible for Fragile X linked mental retardation, different forms of
muscular dystrophy, and most recently Huntington's
disease.
This balance can be disrupted in
diseases such as Duchenne
muscular dystrophy, which is
caused by the lack of a muscle - specific protein, dystrophin.
Spinal
muscular atrophy is a debilitating
disease that
causes weakness and wasting of the muscles.
LONDON — Wellcome Trust, the United Kingdom's largest biomedical research charity, today announced more than # 4 million in support for a pioneering, and potentially controversial, IVF treatment that could prevent some forms of
muscular dystrophy and other
diseases caused by defective mitochondria, the energy - generating organelle in cells.
Johns Hopkins University biologists have found that a protein that plays a key role in the lives of stem cells can bolster the growth of damaged muscle tissue, a step that could potentially contribute to treatments for muscle degeneration
caused by old age and
diseases such as
muscular dystrophy.
Myopathies are frequent
diseases and can be
caused by inherited genetic defects (e.g.,
muscular dystrophies), or by endocrine inflammatory (e.g., polymyositis), and metabolic disorder.
Spinal
Muscular Atrophy (SMA) is a motor neuron
disease and the leading genetic
cause of death among infants and toddlers.
Bar Harbor, Maine — October 21, 2004 — The Jackson Laboratory is pleased to announce that it has received support from the Spinal
Muscular Atrophy Foundation to make available the first group of mouse models for spinal muscular atrophy (SMA), a neuromuscular disease and the leading genetic cause of death among infants and t
Muscular Atrophy Foundation to make available the first group of mouse models for spinal
muscular atrophy (SMA), a neuromuscular disease and the leading genetic cause of death among infants and t
muscular atrophy (SMA), a neuromuscular
disease and the leading genetic
cause of death among infants and toddlers.
Spinobulbar
muscular atrophy, another neurodegenerative
disease caused by increased CAG size
It is characterized by the wasting of skeletal muscles and
caused by progressive degeneration of nerve cells in the spinal cord; the
disease leads to increasing
muscular weakness, atrophy and premature death due to respiratory problems.
This year's ASENT meeting featured a symposium on spinal
muscular atrophy (SMA), an inherited motor neuron
disease that is the second most common autosomal recessive disorder of children and the most common genetic
cause of death in infancy, as a case study in neurology orphan drug development.
Spinal
muscular atrophy is a genetic
disease that
causes the degeneration of spinal cord motor neurons and leads to progressive muscle weakness, atrophy and inability to walk or sit, and breathing difficulties.
Other genetic
diseases include Tay - Sachs
disease (damage to the gene for the enzyme hexosaminidase A leads to an accumulation of a chemical in the brain that destroys it), sickle cell anemia (improper coding of the gene that produces hemoglobin), hemophilia (lack of a gene for a blood - clotting factor) and
muscular dystrophy (
caused by a defective gene on the X chromosome).
Curis Inc. in Cambridge has received a $ 5.4 million, three - year grant from the Spinal
Muscular Atrophy Foundation to identify therapeutic compounds to treat spinal muscular atrophy, a debilitating neuromuscular disease that is the leading genetic cause of infant and toddle
Muscular Atrophy Foundation to identify therapeutic compounds to treat spinal
muscular atrophy, a debilitating neuromuscular disease that is the leading genetic cause of infant and toddle
muscular atrophy, a debilitating neuromuscular
disease that is the leading genetic
cause of infant and toddler death.
Spinal
muscular atrophy (SMA) is a juvenile autosomal recessive form of motor neuron
disease caused by progressive degeneration of motor neurons in the spinal cord.
The condition is more common than
muscular dystrophy and cystic fibrosis, but the development of new therapeutic concepts is hindered by the fact that unlike
muscular dystrophy and cystic fibrosis, where a single mutated gene
causing the
disease is known, the entire human chromosome 21 (containing around 300 genes) still has to be dissected into individual gene - dose contributions to the DS symptoms.
About Spinal
Muscular Atrophy Spinal
Muscular Atrophy is a genetic, motor neuron
disease caused by mutations in a single gene, SMN1.
The Spinal
Muscular Atrophy Foundation awarded the grant to Curis to identify therapeutic compounds that could be used to treat the neuromuscular
disease, which is the leading genetic
cause of infant and toddler death.
Four years ago, researchers identified a genetic mutation associated with spinal
muscular atrophy (SMA), an inherited neuromuscular
disease that is the most common genetic
cause of infant mortality...
SMA is a genetic, neuromuscular
disease caused by progressive degeneration of nerve cells in the spinal cord that leads to
muscular weakness and atrophy and increased risk for early death due to respiratory failure.
Spinal
muscular atrophy (SMA) is a motor neuron
disease and the leading genetic
cause of death among infants and toddlers.
Caused by progressive degeneration of nerve cells in the spinal cord, the
disease leads to increasing
muscular weakness and atrophy.
The most common genetic killer of infants, a
disease known as spinal
muscular atrophy, is
caused by mutations in a single gene.
According to this research, not only will it be possible to develop ways to improve
muscular performance, but also explore
causes of decreased
muscular performance in a variety of
diseases.
Fortunately, through physiological rewiring and neuromuscular re-education, eccentric isometrics help restore and repair the body's optimal physiology by addressing the root
cause of
disease and inflammation, namely
muscular dysfunction.
Toxic heavy metals can
cause, contribute to or accelerate the development of Alzheimer's
disease, Parkinson's
disease,
muscular dystrophy, multiple sclerosis, and other brain and neurological disorders.13
Various
disease such as
muscular dystrophy and liver
disease as well as age can
cause a low creatinine level.
I have a Chronic Pain
Disease, where I am missing a protein in my connective tissue which
causes hypermobility and
muscular knots.
Yes, he wants to put a face on the
disease for researchers who have never met a child with Pompe, a type of
muscular dystrophy in which glycogen build - up
causes extensive
muscular weakness, but that could
cause, as Dr. Kent Webber (Jared Harris), a biotech VP with whom Crowley inevitably clashes heads, puts it, a lack of objectivity, maybe even
causing scientists to cut corners.
One affects the bird's neurological system; one
causes muscular disease and a third affects the bird's lungs and pulmonary system.
Chronic and progressive degeneration of
muscular and ligamentous parts of the body due to any non infectious and congenital (inherited)
disease can
cause weakness in a dog's strength, where the mild stretching and pulling can lead to a sprain.
Many vets feel that the lack of these joints impairs the cat's balance and can
cause weakness from
muscular disease.
Muscular Dystrophies of Golden retrievers, German Short hair pointers and Rottweilers, Devon Rex and Sphynx cats are more of these genetically - based
disease that can be the
cause of high CK levels.
Vets treated acute and chronic wounds from dermatological
diseases to
muscular and skeletal issues
caused by the heavy harnesses that they carry.